Am. J. Respir. Cell Mol. Biol., Vol 15, No. 3, 09 1996, 390-397.
Site-specific responses to monocrotaline-induced vascular injury: evidence for two distinct mechanisms of remodeling
Y Tanaka, ML Bernstein, RP Mecham, GA Patterson, JD Cooper and MD Botney
Department of Medicine, Washington University Medical Center, St. Louis, Missouri, USA.
Monocrotaline (MCT)-induced pulmonary vascular injury was used to begin
studying the mechanism(s) of vascular remodeling in Fischer 344 rats, using
extracellular matrix (ECM) gene expression to define areas of remodeling.
By day 28 after injection, pulmonary artery pressures were increased and
right ventricular hypertrophy had developed compared with normal controls.
Tropoelastin, fibronectin, and alpha 1(I) procollagen mRNA levels increased
at least 2-fold by day 28. In situ hybridization demonstrated tropoelastin
gene expression by cells adjacent to the lumen and procollagen gene
expression at the medial-adventitial border in both small muscular and
large elastic pulmonary arteries. This pattern of gene expression was
observed as early as 1 wk after MCT injury. These observations indicated
two distinct areas of remodeling, one along the vascular lumen at the site
of monocrotaline-induced injury and the other at a second distinct site. To
determine whether other differences may be involved at these two sites, the
presence of transforming growth factor-beta (TGF-beta) was studied. Total
TGF-beta protein was 4-fold higher in remodeling lungs compared with normal
lungs. Gene expression for all three isoforms of TGF-beta colocalized with
tropoelastin gene expression along the vascular lumen but not with alpha
1(I) procollagen gene expression. These results suggest a complex
site-specific response to injury mediated by two distinct pathways in this
model of pulmonary vascular remodeling.
This article has been cited by other articles:

|
 |

|
 |
 
A. Zakrzewicz, F. M. Kouri, B. Nejman, G. Kwapiszewska, M. Hecker, R. Sandu, E. Dony, W. Seeger, R. T. Schermuly, O. Eickelberg, et al.
The transforming growth factor-{beta}/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
Eur. Respir. J.,
June 1, 2007;
29(6):
1094 - 1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T. Vaszar, T. Nishimura, J. D. Storey, G. Zhao, D. Qiu, J. L. Faul, R. G. Pearl, and P. N. Kao
Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats
Physiol Genomics,
April 13, 2004;
17(2):
150 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Jones, L. Mendes, M. A. Rudd, G. Russo, J. Loscalzo, and Y.-Y. Zhang
Serial noninvasive assessment of progressive pulmonary hypertension in a rat model
Am J Physiol Heart Circ Physiol,
July 1, 2002;
283(1):
H364 - H371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. BOTNEY
Role of Hemodynamics in Pulmonary Vascular Remodeling . Implications for Primary Pulmonary Hypertension
Am. J. Respir. Crit. Care Med.,
February 1, 1999;
159(2):
361 - 364.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. OKADA, M. L. BERNSTEIN, W. ZHANG, D. P. SCHUSTER, and M. D. BOTNEY
Angiotensin-converting Enzyme Inhibition Delays Pulmonary Vascular Neointimal Formation
Am. J. Respir. Crit. Care Med.,
September 1, 1998;
158(3):
939 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society.
|
|
|